Search details
1.
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.
Immunity
; 46(2): 197-204, 2017 02 21.
Article
in English
| MEDLINE | ID: mdl-28228279
2.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Article
in English
| MEDLINE | ID: mdl-38554725
3.
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs.
Nature
; 575(7781): 229-233, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31666694
4.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer
; 129(23): 3772-3782, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37769113
5.
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.
Br J Cancer
; 127(11): 2072-2085, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36175617
6.
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
Cancer
; 127(8): 1311-1317, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33296083
7.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33910263
8.
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
Br J Cancer
; 125(5): 687-698, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34140638
9.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29466156
10.
Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas.
Oncology
; 99 Suppl 1: 3-7, 2021.
Article
in English
| MEDLINE | ID: mdl-33853076
11.
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome.
Proc Natl Acad Sci U S A
; 115(25): E5746-E5755, 2018 06 19.
Article
in English
| MEDLINE | ID: mdl-29866822
12.
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Lancet Oncol
; 21(11): 1423-1432, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33035459
13.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31838007
14.
Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers.
Future Oncol
; 16(9): 417-425, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-32129093
15.
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
Cancer
; 125(24): 4435-4441, 2019 Dec 15.
Article
in English
| MEDLINE | ID: mdl-31503332
16.
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Cancer
; 125(15): 2610-2620, 2019 08 01.
Article
in English
| MEDLINE | ID: mdl-31173362
17.
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer
; 121(3): 281, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31123346
18.
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer
; 120(6): 612-620, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30792533
19.
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses.
BMC Cancer
; 19(1): 794, 2019 Aug 13.
Article
in English
| MEDLINE | ID: mdl-31409302
20.
The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.
Br J Clin Pharmacol
; 85(10): 2399-2404, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31290566